| James A Mish |
James A Mish is currently the President & Chief Executive Officer at Purisys LLC since 2019. He is also a Director at 22nd Century Group, Inc. since 2020 and a Director at Psilotec Health Solutions, Inc. He previously served as the Chief Executive Officer at Noramco, Inc. and as a Director at Exactus, Inc. From 2013 to 2016, he was the Group Vice President-Care Specialties at Ashland LLC. Mr. Mish completed his undergraduate degree at The Pennsylvania State University and also holds an undergraduate degree from The Wharton School of the University of Pennsylvania. |
| Calvin Treat |
Calvin Treat holds the position of Chief Scientific Officer for 22nd Century Group, Inc.
He received a doctorate and a graduate degree from the University of Wisconsin, an MBA from the University of Nebraska Omaha and an undergraduate degree from The University of Nebraska-Lincoln. |
| Robert Hugh Kinsman |
Robert Hugh Kinsman is currently the Co-Chief Financial Officer at 22nd Century Group, Inc. since 2024 and the Chief Financial Officer at GVB Biopharma since 2020. Previously, he worked as an Advisory Director at First New England Capital, a Managing Director at Full Circle Capital Corp. from 2007 to 2009, a Senior Associate at General Electric Capital Corp. in 1998-1999, a Principal at Summit Bank (Summit, New Jersey), a Principal at Fleet Bank, NA (Hartford, Connecticut), and a Partner at WS Capital LLC (Connecticut) from 1997 to 2007. He also served as the Chief Financial Officer at iQ International AG. Kinsman holds an MBA from Cornell University and an undergraduate degree from The Pennsylvania State University. |
| John J. Miller |
John J. Miller is the President-Tobacco Business at 22nd Century Group, Inc. He previously served as the President at Swisher International, Inc. from 2018 to 2021. Mr. Miller holds an MBA from Pepperdine University and an undergraduate degree from Lee Business School. |
| Juan Sanchez Tamburrino |
Juan Sanchez Tamburrino is currently the Vice President-Research & Development at 22nd Century Group, Inc. He previously worked as the Head-Plant Biotechnology at British American Tobacco plc from 2009 to 2016. Prior to that, he worked as an Associate Professor at Universidad de Tarapacá from 2003 to 2005. He also worked as a Research Manager at DuPont Pioneer. Dr. Tamburrino holds an MBA degree from the University of Bradford and a doctorate degree from Weill Cornell Graduate School of Medical Sciences. |
| Lawrence D. Firestone |
Lawrence D. Firestone founded Firepower Technology, Inc. in 2014, where he worked as President & Chief Executive Officer. Mr. Firestone also currently works at 22nd Century Group, Inc., as Chairman & Chief Executive Officer from 2023 and Association of Interim Executives, as Member. Mr. Firestone also formerly worked at Qualstar Corp., as President, Chief Executive Officer & Director from 2012 to 2013, PC Power & Cooling, Inc., as Chief Executive Officer, Amtech Systems, Inc., as Director from 2005 to 2007, CVD Equipment Corp., as Independent Director from 2014 to 2016, HyperSpace Communications, Inc., as Director from 2004 to 2005, Eastside Distilling, Inc., as Director in 2020, Advanced Energy Industries, Inc., as CFO, EVP & Head-Investor Relations in 2010, Applied Films Corp., as Chief Financial Officer, Secretary & Treasurer in 2006, Axellio Inc., as Chief Financial Officer, SITO Mobile Ltd., as Chief Financial Officer in 2017, Akonni Biosystems, Inc., as Chief Financial Officer & Executive Vice President, and Avalanche Industries, Inc., as Chief Operating Officer & Vice President from 1996 to 1999. Mr. Firestone received his undergraduate degree in 1981 from Slippery Rock University. |
| Michael Koganov |
Michael Koganov is the President and founder of Intellebio LLC, which is founded in 2019. He is also the founder of IBT LLC. Currently, he holds the position of Independent Director at 22nd Century Group, Inc. since 2020. Dr. Koganov has a graduate degree from Dnipropetrovsk National University and a doctorate degree from Ukrainian State University of Chemical Technology. |
| Anthony Johnson |
Anthony Johnson is the founder of Kodikaz Therapeutic Solutions, Inc. He currently holds positions as an Independent Director at 22nd Century Group, Inc., Director at WNED, Member at Aspen Global Leadership Network, and Founding Partner at Buffalo Biosciences LLC. His former positions include President & Chief Executive Officer at Empire Genomics, Inc., Director at Public Broadcasting Service, and Council Member at State University of New York at Buffalo. Mr. Johnson received his undergraduate degree from Fisk University and his MBA from Manchester Business School. |
| Richard M. Sanders |
Richard M. Sanders is an Independent Director at 22nd Century Group, Inc. and a General Partner at Phase One Ventures LLC. He was previously the President & Chief Executive Officer at Santa Fe Natural Tobacco Co., Inc. and Senior Vice President-Marketing at R.J. Reynolds Tobacco Co. He also served as a Director at Aqua Membranes, Inc. Sanders holds an MBA from Washington University in St. Louis and an undergraduate degree from Hamline University. |
| Andrew Arno |
Andrew Arno is the founder of Unterberg Capital LLC, which was founded in 2009. He held the title of Vice Chairman & Chief Marketing Officer from 2009 to 2012. Mr. Arno's current job(s) include being the Chairman, CEO, CFO & Secretary at ComHear, Inc. since 2017, Chairman at OncoCyte Corp. since 2015, Independent Director at Smith Micro Software, Inc. since 2011, Independent Director at 22nd Century Group, Inc. since 2023, Director at Independa, Inc., Treasurer & Director at The Jewish Community Center in Manhattan, Inc., and Director at New York Service for the Handicapped. Mr. Arno's former job(s) include being the Chairman & Chief Executive Officer at C. E. Unterberg, Towbin Advisors LP, Chairman & Chief Executive Officer at C. E. Unterberg, Towbin, Inc. from 1990 to 2007, Chairman & Chief Executive Officer at Collins Stewart LLC from 2007 to 2008, Vice Chairman at Merriman Holdings, Inc. from 2009 to 2011, Vice Chairman & Head-Equity Capital Markets at Merriman Capital, Inc., Vice Chairman at Chardan Capital Markets LLC from 2013 to 2015, Chairman at Collins Stewart LLC (Investment Management) from 2007 to 2008, Vice Chairman at Bradley Woods & Co. Ltd. from 2013 to 2015, Vice Chairman at The Special Equities Group LLC, Managing Director at Emerging Growth Equities Ltd. from 2013 to 2015, Independent Director at Asterias Biotherapeutics, Inc. from 2014 to 2019, Vice President at Lehman Brothers, Inc. from 1987 to 1989, President at Loewen, Ondaatje, McCutcheon USA Ltd., Vice President at L. F. Rothschild, Unterberg, Towbin, Inc. from 1981 to 1986, Vice President at Sabr Group, Inc. from 2013 to 2015, and President at Lomusa Ltd. from 2009 to 2012. Mr. Arno's education history includes undergraduate studies at George Washington University. |
| Lucille S. Salhany |
Lucille S. Salhany founded Echo Bridge Entertainment LLC in 2003, where she worked as Director from 2010 to 2011. Ms. Salhany also currently works at J.H. Media Ltd., as President & Chief Executive Officer from 1997, 22nd Century Group, Inc., as Independent Director from 2022, and Savana, Inc., as Director. Ms. Salhany also formerly worked at LifeF, as President & Chief Executive Officer from 1999 to 2002, United Paramount Network, as President & Chief Executive Officer from 1999 to 2002, LifeFX Networks, Inc., as President & Chief Executive Officer from 1999 to 2002, Fox Broadcasting Co. LLC, as Chairman from 1993 to 1994, Twentieth Television, Inc., as Chairman from 1991 to 1993, Compaq Computer Corp., as Director from 1997 to 2002, HP, Inc., as Director from 2002 to 2011, ION Media Networks, Inc., as Director from 2006 to 2008, Boston Restaurant Associates, Inc., as Director, and Fox, Inc., as Director. |
